39 related articles for article (PubMed ID: 7727458)
1. CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation.
Fossum B; Olsen AC; Thorsby E; Gaudernack G
Cancer Immunol Immunother; 1995 Mar; 40(3):165-72. PubMed ID: 7728775
[TBL] [Abstract][Full Text] [Related]
2. Indirect presentation of donor histocompatibility antigens contributes to the allogeneic response against human cardiac myocytes.
Ansari AA; Wang YC; Kanter K; Naucke N; Sell KW
J Heart Lung Transplant; 1992; 11(3 Pt 1):467-77; discussion 477-8. PubMed ID: 1535220
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
4. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human heart-infiltrating cells after transplantation. VI. Differences in the cytokines produced by individual CD4+ cloned T-cell lines with apparently identical antiidiotype-like reactivity.
Sell KW; Wang YC; Kanter K; Rodey GE; Mayne A; Ansari AA
J Heart Lung Transplant; 1992; 11(3 Pt 1):511-21. PubMed ID: 1351745
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of human cardiac allograft rejection: absence of co-stimulatory molecules and cell adhesion molecules on major histocompatibility complex class I/II+ human cardiac myocytes does not induce anergy.
Sundstrom JB; Mayne A; Kanter K; Herskowitz A; Ansari AA
Transplant Proc; 1995 Feb; 27(1):1310-3. PubMed ID: 7878895
[No Abstract] [Full Text] [Related]
7. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
[TBL] [Abstract][Full Text] [Related]
8. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
9. [Endomyocardial biopsy in the heart transplant patient: the state of the art].
Arbustini E; Grasso M; Diegoli M; Gavazzi A; Campana C; Martinelli L; Goggi C; Pucci A; Grossi P; Ippoliti G
G Ital Cardiol; 1991 Oct; 21(10):1107-23. PubMed ID: 1804749
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cardiac allograft rejection and avenues for immunological monitoring.
Rose ML; Yacoub MH
Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):162-74. PubMed ID: 2081226
[No Abstract] [Full Text] [Related]
11. Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'.
Kanangat S
Int J Immunogenet; 2017 Feb; 44(1):1-6. PubMed ID: 28044415
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
